Development of a Novel Inhibitor of ADP-Ribosylation Factor 1 (Arf1) That Has Potential for Cancer Therapy

被引：0
|
作者：
Ohashi, Y. [1 ]
Iijima, H. [2 ]
Yamaotsu, N. [2 ]
Yamazaki, K. [1 ]
Okamura, M. [1 ]
Sugimoto, K. [3 ]
Hirono, S. [2 ]
Dan, S. [1 ]
Yamori, T. [1 ]
机构：
[1] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Mol Pharmacol, Tokyo 170, Japan
[2] Kitasato Univ, Sch Pharm, Tokyo, Japan
[3] Osaka Prefecture Univ, Lab Appl Mol Biol, Div Appl Biochem, Grad Sch Agr & Biol Sci, Osaka, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)72310-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
513
引用
收藏
页码：158 / 158
页数：1
相关论文
共 50 条
  • [21] Coconut oil decreases expression of amyloid precursor protein (APP) and secretion of amyloid peptides through inhibition of ADP-ribosylation factor 1 (ARF1)
    Bansal, Ananya
    Kirschner, Megan
    Zu, Li
    Cai, Dongming
    Zhang, Lumin
    BRAIN RESEARCH, 2019, 1704 : 78 - 84
  • [22] ADP-ribosylation factor 1 (ARF1) takes part in cell proliferation and cell adhesion-mediated drug resistance (CAM-DR)
    Xiaohong Xu
    Qiru Wang
    Yunhua He
    Linlin Ding
    Fei Zhong
    Yangyu Ou
    Yaodong Shen
    Hong Liu
    Song He
    Annals of Hematology, 2017, 96 : 847 - 858
  • [23] Kinetics of Interaction between ADP-ribosylation Factor-1 (Arf1) and the Sec7 Domain of Arno Guanine Nucleotide Exchange Factor, Modulation by Allosteric Factors, and the Uncompetitive Inhibitor Brefeldin A
    Rouhana, Jad
    Padilla, Andre
    Estaran, Sebastien
    Bakari, Sana
    Delbecq, Stephan
    Boublik, Yvan
    Chopineau, Joel
    Pugniere, Martine
    Chavanieu, Alain
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (07) : 4659 - 4672
  • [24] Expression, purification, and properties of ADP-ribosylation factor (ARF) GTPase activating protein-1
    Huber, I
    Rotman, M
    Pick, E
    Makler, V
    Rothem, L
    Cukierman, E
    Cassel, D
    REGULATORS AND EFFECTORS OF SMALL GTPASES, PT E, 2001, 329 : 307 - 316
  • [25] Identification of the minimal region of peptide derived from ADP-ribosylation factor1 (ARF1) that inhibits IgE-mediated mast cell activation
    Uchida, Ryota
    Egawa, Tomonori
    Fujita, Yoshio
    Furuta, Kazuyuki
    Taguchi, Hiroaki
    Tanaka, Satoshi
    Nishida, Keigo
    MOLECULAR IMMUNOLOGY, 2019, 105 : 32 - 37
  • [26] Role of ADP-ribosylation factors (ARF1 and ARF6) in regulation of receptor-mediated endocytosis in kidney proximal tubules.
    Marshansky, V
    Maranda, B
    Bourgoin, S
    Londono, I
    Bendayan, M
    Vinay, P
    MOLECULAR BIOLOGY OF THE CELL, 1997, 8 : 824 - 824
  • [27] Structure of Plasmodium falciparum ADP-ribosylation factor 1
    Cook, William J.
    Smith, Craig D.
    Senkovich, Olga
    Holder, Anthony A.
    Chattopadhyay, Debasish
    ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2010, 66 : 1426 - 1431
  • [28] Binding site of brefeldin A at the interface between the small G protein ADP-ribosylation factor 1 (ARF1) and the nucleotide-exchange factor Sec7 domain
    Robineau, S
    Chabre, M
    Antonny, B
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (18) : 9913 - 9918
  • [29] A locust type 1 ADP-ribosylation factor (IARF1)* is 100% identical in amino acid sequence to Drosophila ARF1 despite obvious DNA sequence divergence
    Hannan, F
    Evans, PD
    INSECT MOLECULAR BIOLOGY, 2000, 9 (06) : 559 - 563
  • [30] ADP-ribosylation factor 1 (ARF1) protein interacts with elicitor PvNLP7 from Plasmopara viticola to mediate PvNLP7-triggered immunity
    Xiang, Jiang
    Wei, Lingzhu
    Zheng, Ting
    Wu, Jiang
    Cheng, Jianhui
    PLANT SCIENCE, 2024, 347
12345